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ABSTRACT"31" !32"
The"airways"of"most"people"with"cystic"fibrosis"are"colonized"with"biofilms"of"33"
the"Gram`negative,"opportunistic"pathogen"Pseudomonas*aeruginosa."34"
Delivery"of"antibiotics"directly"to"the"lung"in"the"form"of"aerosols"or"dry"35"
powders"offers"the"potential"to"achieve"high"local"concentrations"directly"to"36"
the"biofilms."Unfortunately,"current"aerosolised"antibiotic"regimes"are"unable"37"
to"efficiently"eradicate"these"biofilms"from"the"airways."We"investigated"the"38"
ability"of"the"innate"antimicrobial,"lactoferrin,"to"enhance"the"activity"of"two"39"
aminoglycoside"antibiotics"(tobramycin"and"gentamicin)"against"biofilms"of"P.*40"
aeruginosa"strain"PAO1."Biofilms"were"prepared"in"96"well"polystyrene"plates."41"
Combinations"of"the"antibiotics"and"various"lactoferrin"preparations"were"42"
spray"dried."The"bacterial"cell"viability"of"the"various"spray"dried"combinations"43"
were"determined.""Iron`free"lactoferrin"(apo"lactoferrin)"induced"a"3"log"44"
reduction"in"the"killing"of"planktonic"cell"by"the"aminoglycoside"antibiotics"(p"<"45"
0.01)"and"also"reduced"both"the"formation"and"persistence"of"P.*aeruginosa"46"
biofilms"(p"<"0.01)."Combinations"of"lactoferrin"and"an"aminoglycoside"47"
displays"potential"as"an"effective"new"therapeutic"strategy"in"the"treatment"of"48"
P.*aeruginosa"biofilms"infections"such"as"those"typical"of"the"CF"lungs."49"
"50"
"51"
KEYWORDS:"Antimicrobial"protein,"spray"drying,"Pseudomonas"aeruginosa,"52"
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1." INTRODUCTION"55"
P.*aeruginosa" biofilms"have"been" recognised"as"one"of" the"most" persistent"56"
microbe"community"in"the"airway"of"people"with"cystic"fibrosis"(CF)"(Singh"et"57"
al.,"2002]"Banin"et"al.,"2006]"Costerton"et"al.,"1999]"Musk"and"Hergenrother,"58"
2008]" Van" Delden" and" Iglewski," 1998)." We" now" understand" that" P.*59"
aeruginosa"are"able"to"form"these"biofilms"by"assembling"viable"cells"together"60"
to" form" a" cooperative" consortium" encased" within" an" exopolysaccharide" (or"61"
glycocalyx)" (Gomez"and"Prince,"2007]"Lam"et"al.,"1980]"Singh"et"al.,"2000)."62"
The"exopolysaccharide"formed"specialises"in"attaching"to"a"variety"of"surfaces"63"
(Mah" and" O'Toole," 2001)." Consequently," the" presence" of" P.* aeruginosa"64"
biofilms" at" any" stage" of" infection" usually" results" in" recurrent" bacterial"65"
infections" due" to" the" ability" of" dispersed" planktonic" daughter" cells" released"66"
from"Pseudomonas"biofilms"to"colonise"new"surfaces"(Hoiby"et"al.,"2001)."67"
Currently," in"other" to"manage" the"high" incidences"of"mortality" resulting" from"68"
chronic"colonization"of"P.*aeruginosa"in"the"airways,"clinicians"have"employed"69"
the" use" of" aerosolised" antibiotics" (O" Riordan," 2000]" Ramsey" et" al.," 1993)."70"
Many" of" the" established" antibiotic" therapies" such" as" colistimethate" sodium"71"
and"tobramycin"are"delivered"to"the"CF"airways"using"nebulisers."Nebulising"72"
medication" is" time" consuming" and" requires" the" use" of" expensive" nebuliser"73"
apparatus" that" require" maintenance." Both" these" factors" increase" the"74"
treatment" burden" and" may" reduce" compliance" and," therefore," treatment"75"
efficacy."New"dry"powder" inhaler"(DPI)"formulations"of"colistimethate"sodium"76"
(Colobreathe]" Forest" Laboratories," Dartford," UK)" and" tobramycin" (TOBI"77"
Podhaler]"Novartis"Pharmaceuticals,"Camberley,"UK)"have"become"available,"78"
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delivered" by" convenient" portable" mechanisms" (Turbospin" device" (Forest"79"
Laboratories)"and"T`326"Inhaler"(Novartis"Pharmaceuticals))."The"benefits"of"80"
dry"powder"antibiotics"are"that"they"are"quicker"to"use"and"easier"to"maintain"81"
than" traditional"nebulised" therapy,"which"may" thereby" improve"adherence" to"82"
the"therapy"83"
Although"aerosolised"antibiotic" therapy"has" its"merits," such"as]" the"ability" to"84"
achieve" high" local" concentrations" in" the" airways," decrease" systemic" toxicity"85"
and"successful"suppression"of"established"planktonic"P.*aeruginosa"cells"it"is"86"
relatively" inefficient" in" the"eradication"of"persistent"biofilms"of"P.*aeruginosa"87"
(A."L."Smith"et"al.,"1999)." In" fact,"several"studies"have"suggested" that"when"88"
bacterial" cells" exist" in" biofilms," they" can" become" 10" –" 1000" times" more"89"
resistant" to" the" effects" of" antimicrobial" agents" (Rogan" et" al.," 2004]" Smith,"90"
2005)"as"well"as"to"the"effects"of" immune"cells"(Leid"et"al.,"2002]"Jesaitis"et"91"
al.," 2003)."Evidence" from"several" studies" suggests" that" once"P.* aeruginosa"92"
biofilms" are" established" in" the" airways," they" become" a" formidable," highly"93"
organized" and" resistant" pathogen" with" fatal" consequences" for" the" host."94"
Hence,"loss"of"any"defence"mechanism"by"the"host"that"may"facilitate"biofilms"95"
development"could"result"in"catastrophic"consequences"(Rogan"et"al.,"2004).""96"
The"antimicrobial"peptides"and"proteins"(AMP)"form"an"important"component"97"
of" innate" immune" defences`" the" primary" defence" system" of" the" majority" of"98"
living" organisms." These" AMP’s" are" present" in" high" concentrations" on"99"
respiratory" epithelia" and" are" able" to" delay" or" prevent" microbial" growth"100"
following" an" infection." Usually," they" can" act" for" several" hours" until" the"101"
adaptive" immune" system" is" sufficiently"mobilised" to" the" site" of" infection."An"102"
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example"of"one"of"these"AMP’s"is"lactoferrin,"a"glycoprotein"of"about"80"kDa"103"
found"in"high"concentration"in"most"exocrine"secretions"including"milk,"tears,"104"
saliva," genital" secretions," intestinal" mucus" and" in" the" specific" granule" of"105"
neutrophils" (Ellison," 1994)." Various" biological" functions" of" lactoferrin" –" i.e."106"
anti`microbial," anti`inflammatory" and" immunomodulatory" –" have" been"107"
described"(Tomita"et"al.,"2002).""108"
Lactoferrin" displays" antibacterial" effects" against" planktonic" Gram`negative"109"
microbes" by" two" mechanisms]" (i)" impairment" of" bacterial" multiplication" by"110"
decreasing" the" availability" of" iron" which" is" required" for" bacterial" growth"111"
(Rogan" et" al.," 2004]" Arnold" et" al.," 1982)" and" (ii)" disruption" the" outer"112"
membrane"of"the"microbes"by"binding"to"lipopolysaccharide"(LPS)"this"results"113"
in" an" altered" permeability" eventually" resulting" in" the" death" of" the" microbe"114"
(Elass`Rochard"et"al.,"1995]"Appelmelk"et"al.,"1994)."More"recently,"lactoferrin"115"
has" been" shown" to" inhibit"P.* aeruginosa" biofilm" formation" by" sequestering"116"
iron" from" the"microbe" (Singh"et"al.," 2002)."This"biofilm" inhibitory"property" is"117"
unique" to" lactoferrin" and" is" a" pivotal" role" in" host" defence" against" invading"118"
microbes." Several" studies" have" so" far" shown" that" lactoferrin" is" able" to"119"
enhance" the"antimicrobial"properties"of"some"antibiotics" (Leitch"and"Willcox,"120"
1999)." This" is" particularly" interesting" since" currently" inhaled" antibiotics" (for"121"
example" tobramycin)" has" been" frequently" associated" with" emergence" of"122"
resistant"strains"(O"Riordan,"2000]"Costerton"et"al.,"1999]"Allison"et"al.,"2011)."123"
The" aim" of" the" present" study" was" to" investigate" the" development" of"124"
combination" DPI" formulations" of" lactoferrin" with" other" anit`microbial" agents"125"
using"spray"drying."The"further"focus"of"our"study"was"to" investigate"if" these"126"
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treatment" strategies" permit" the" prevention" of" biofilm" formation" and/or"127"
disruption" of" persistent" biofilms" of"P.* aeruginosa" in" patients" whose" airways"128"
have"been"compromised"to"P.*aeruginosa"infection.""129"
"130"
2." METHODS"AND"MATERIALS"131"
"132"
2.1"Bacterial"strains."133"
"""134"
P.*aeruginosa" strain"PAO1"was" routinely"grown" from"CAA"medium`"nutrient"135"
medium"containing"casamino"acids"(CAA,"0.5%"w/v)"supplemented"with"1mM"136"
magnesium"chloride.""For"the"biofilm"penetration"assays,"the"BSAC"standard"137"
Escherichia* coli" NCTC" 10418"was" used" and"was" grown" overnight" in" Luria`138"
Bertani"(LB)"broth."139"
"140"
2.2"Production"of"iron`free"lactoferrin"(apolactoferrin]"ApoLf)."""141"
"142"
Apolactoferrin"was"prepared"by"dialyzing"bovine"lactoferrin"(kindly"donated"by"143"
DMV"Fonterra,"Netherlands)"against"20"mM"sodium"acetate,"20"mM"sodium"144"
dihydrogen" phosphate" and" 40" mM" EDTA" (pH" 3.5)" for" 24" hrs" at" 4°C." The"145"
apolactoferrin"was" dialysed" against" at" least" two" changes" of" 900"ml" distilled"146"
water"and"either"used"immediately"or"stored"at"`80°C"until"needed."Ferric"ion"147"
(Fe3+)" removal" was" confirmed" by" atomic" absorption" spectroscopy" (data" not"148"
shown)."149"
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"150"
2.3" Production" and" charcaterisation" of" mono" and" combination" particles" of"151"
lactoferrin"and"apolactoferrin"with"Tobramycin"or"Gentamicin."152"
"""153"
A" spray" drying" technique"was"employed" for" the" preparation" of"micron`sized"154"
particles" of" lactoferrin" (LF)," apo`lactoferrin" (ApoLf)" tobramycin" (Tobi)" and"155"
gentamicin"(Genta)."Aqueous"solutions"of"each"material"(2%"w/v)"was"spray`156"
dried" using" a" Büchi" 290" Mini" Spray" Dryer" with" pneumatic" atomizer" with" a"157"
7mm"aperture," air" (prior" relative" humidity" 20%)" aspirator" rate" 35"m3/h," feed"158"
pump"5"mL/min," spray" flow" rate" 700" L/h," inlet" air" temperature" 180–" 190°C,"159"
outlet"temperature"96–98°C."160"
Inhalable"combination"particles"of"each"antibiotic"and"LF"and"ApoLf"were"also"161"
produced"by"spray"drying."Aqueous"solutions"of" tobramycin"and"gentamycin"162"
with" and" with" micronisation" of" the" different" formulations" using" a" (Büchi"163"
Laboratoriums`Technik"AG,"Flawil,"Switzerland).""164"
For"particle"sizing,"dry"powders"were"dispersed"with"compressed"air" (3"bar)"165"
and" sized" by" laser" diffraction" (RODOS" dry" powder" feeder]" HELOS" laser"166"
diffractometer,"WINDOX"4.0"software]"Sympatec"GmbH,"Germany)."The"10%,"167"
50%"and"90%"undersize"particle"size"values"(X10,"X50"and"X90,"respectively)"168"
were"obtained.""169"
The" in" vitro" aerosolisation" performance" of" the" dry" powders" was" measured"170"
using"a"Multi`stage"liquid"impinge"(MSLI,"Copley"Scientific,"Nottingham,"UK)."171"
The" four" stages"of" the"MSLI"were" charged"with" 20"mL"of"water."A" vacuum"172"
pump"was"attached"to"the"MSLI"and"the"flow"rate"was"set"at"a"flow"rate"of"60"173"
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L/min" using" a" digital" flowmeter" (DFM2000," Copley" Scientific," Nottingham,"174"
UK)."Approximately"30"±"2"mg"of"each"of"spray"dried"powders"was"manually"175"
weighed" into" a" size"3" hard"hydroxypropyl"methylcellulose" (HPMC)" capsules"176"
(V`caps," Capsugel," Geel," Belgium)." A" capsule" was" placed" into" the" capsule"177"
compartment" of" a" CyclohalerTM" DPI" device" (Pharmachemie" BV," The"178"
Netherlands)," pierced" and" actuated" for" 4" s." Powders" depositing" in" the" four"179"
impinger"levels"were"recovered"by"agitating"the"apparatus"to"ensure"complete"180"
dissolution."The"powder"which"deposited"in"the"throat"and"the"back"filter"were"181"
also"collected"and" the"amount"of"protein"depositing" in"each"of" these"stages"182"
determined" by" carrying" out" bicinchoninic" acid" (BCA)" assay" or" using" a" high"183"
performance" liquid" chromatography" (HPLC)" assay" for" the" detection" and"184"
quantification"of"either"Tobi"or"Genta.""185"
Quantitation" of" total" protein"was" carried" out" according" to" the"manufacturing"186"
instructions" accompanying" a" BCA" assay" kit" (Sigma" Aldrich," Poole," UK)."187"
Briefly," bovine" serum" albumin" standards" were" prepared" by" diluting" the"188"
contents"of"a"1"mL"ampoule"containing"2"mg"of"albumin"(to"prepare"standard"189"
concentrations" of" 20" –" 2000" μg/mL)." The" working" reagent" was" prepared"190"
mixing"50"parts"of"BCA"reagent"A"with"1"part"of"BCA"reagent"B."Then"a"200"191"
μL"aliquot" of" the"working" reagent"was"added" into"each"of" the"wells" already"192"
containing"25"μL"of"either"standard"or" test"protein."The"plates"were"covered"193"
and"incubated"at"37"°C"for"30"minutes,"then"cooled"to"room"temperature"and"194"
then" the" absorbance" measured" at" 562" nm" using" a" Multiskan" Spectrum" `"195"
UV/Vis"Microplate"Spectrophotometer."196"
Tobi"was"separated"and"quantified"by"HPLC"(Agilent"1260,"London,"UK)"using"197"
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an" isocratic"mobile" phase" consists" of" buffer" 0.05"M" diammonium" hydrogen"198"
phosphate," pH" adjusted" to" 10.0" using" tetramethyl" ammonium" hydroxide."199"
Chromatography"was"carried"out"at"25°C"on"a"Purosphere"RP`8e,"250"mm"×"200"
4.6"mm,"5mm"(Merck"KGaA,"Darmstadt,"Germany)."The"detection"was"carried"201"
out"using"variable"wavelength"UV`Vis"detector"set"at"210"nm."The"compounds"202"
were"eluted"isocratically"at"a"steady"flow"rate"of"1.0"mL/min."Gentamicin"was"203"
separated" and" quantified" by" HPLC" (Agilent" 1260," London," UK)" using" an"204"
isocratic"mobile" phase"was" 48.5mM"TFA–MeOH" (97:3," v/v)" and" ran" at" flow"205"
rate"of"0.7"ml/min."Chromatography"was"carried"out"at"25°C"on"a"Hypurity"RP"206"
18,"3µm,"125"mm"x"4"mm"i.d."(Thermo"Hypersil,"Runcorn,"UK."The"detection"207"
was" carried" out" using" an" evaporative" light" scattering" detector" (Agilent,"208"
London,"UK)."209"
The" aerosolisation" performance" of" the" different" spray`dried" powders" were"210"
characterised" by" comparing" the" percentage" emitted" fraction" (%EF,"211"
percentage"collected"from"all"stages"of"MSLI"as"a"function"of"recovered"dose)"212"
and"fine"particle"fraction"of"the"recovered"dose"(FPFRD,"percentage"of"FPD"to"213"
RD)"of"the"respective"spray`"dried"powders."The"%EF,"FPFRD"were"expressed"214"
as"the"means"of"quintuplicate"runs"(n"="5).""215"
""216"
2.4"Viability"assay"for"planktonic"bacterial"killing."""217"
"218"
The"antimicrobial"activity"of"Lf"and"apoLf,"alone"and" in"combination"with" the"219"
aminoglycosides," towards"planktonic"bacteria"was"assessed"using"a"viability"220"
assay.""Briefly,"10µL"of"~"6.6"x"107"CFU/ml"PAO1"was"incubated"with"90"µL"of"221"
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2"µg/ml"of"Lf,"ApoLf"or"combinations"of"protein"with"aminoglycoside."Samples"222"
were"taken"every"10"mins,"diluted" in"deionised"water"and"plated"on"Mueller`223"
Hinton" agar." Following" 24" h" incubation" at" 37°C," colonies" were" enumerated"224"
and"the"percentage"of"viable"cells"was"determined"relative"to"the"cell"count"in"225"
the"absence"of"proteins/antibiotics."226"
"227"
2.5"Qualitative"analysis"of"biofilms."""228"
"229"
Crystal" violet" staining" was" used" to" assess" the" effects" of" spray`dried"230"
formulations"of"Lf,"ApoLf"and"combinations"of"proteins"with"aminoglycosides"231"
on"biofilm"formation"by"PAO1.""Overnight"cultures"were"diluted"1:100"(v/v)"into"232"
fresh"medium"supplemented"with"magnesium"chloride,"glucose"and"casamino"233"
acids." " In" order" to" examine" the" effects" of" compounds" on" biofilm" formation,"234"
aliquots" were" dispensed" into" a" 96" well" plate" in" the" presence" of" the"235"
compounds"at"2 g/ml." "Plates"were" incubated"at"37°C" for"24"h,"after"which"236"
time"excess"broth"was"removed"and"the"biofilm"was"stained"with"crystal"violet.""237"
In" order" to" examine" the" effects" of" the" compounds" on" a" pre`formed" biofilm,"238"
overnight"cultures,"diluted"1:100"as"above,"were" incubated"at"37°C" for"24"h"239"
before"compounds"were"added"and"plates"incubated"for"a"further"24h"prior"to"240"
biofilm"staining.""In"both"cases,"following"the"appropriate"incubation"times,"the"241"
adherent" biofilm" was" washed" twice" with" distilled" water" before" staining" with"242"
0.1%" (w/v)" crystal" violet" in" distilled"water" for" 15"mins" at" room" temperature."243"
Following"vigorous"washing"with"water,"the"crystal"violet`stained"biofilms"were"244"
solubilised" in" 30%" (v/v)" acetic" acid" and" the" absorbance" at" 550nm" was"245"
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determined"(Multiskan"spectrum"plate"reader)"using"30%"acetic"acid"in"water"246"
as"the"blank."247"
"248"
2.6"Preparation"of"biofilms"for"penetration"assays.""249"
"250"
Biofilms"of"P.*aeruginosa"were"prepared"according"to"a"method"adapted"from"251"
Anderl"et*al."(2000)."Briefly,"cultures"of"P.*aeruginosa"were"grown"overnight"at"252"
37°C" in" casamino" acid"media" supplemented" with"magnesium" chloride." The"253"
bacterial" culture" was" diluted" to" give" ca." 106" cfu/ml" and" 5" µL" of" this" diluted"254"
inoculum"was"used"to"seed"a"UV`sterilised"13"mm"diameter,"0.2 m"pore"size"255"
polycarbonate" nucleopore" membrane" (Whatman)." Membranes" were" placed"256"
on" Mueller`Hinton" agar" (MHA)" plates" and" incubated" for" 24h" at" 37°C" after"257"
which" time" they" were" transferred" onto" fresh" MHA" for" a" further" 24h." " This"258"
established"biofilm"was"then"used"in"the"assembly"depicted"in"Fig."1."259"
"260"
2.7"Biofilm"penetration"assay."""261"
"262"
E*coli"NCTC"10148"was"grown"overnight"in"Luria`Bertani"(LB)"broth"before"the"263"
density"was"adjusted"to"a"0.5"McFarland"standard"and"applied"to"MHA"plates"264"
to" enable" the" growth" of" a" confluent" lawn." The" biofilm" penetration" of"265"
tobramycin"and"gentamicin,"either"alone"or"in"combination"with"the"lactoferrin"266"
preparations," was" determined" using" a" method" modified" from" Singh" et* al."267"
(2010)."Briefly," the"membranes"supporting"biofilm"growth"were"transferred"to"268"
MHA" plates" inoculated" with"E.* coli." A" UV`sterilised" 6"mm" diameter," 0.2 m"269"
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pore"size"nucleopore"polycarbonate"membrane"(Whatman)"was"placed"on"top"270"
of"each"biofilm"together"with"the"antibiotic"disc,"containing"the"compounds"of"271"
interest."All"plates"were"incubated"at"37°C"for"24"h"before"the"diameters"of"the"272"
clear"zones"of"inhibition"of"growth"were"measured."273"
"274"
Controls" comprising" of"membranes" and" antibiotic" discs"without" biofilms" and"275"
biofilms" with" “empty”" discs" were" also" set" up." Antibiotic" discs" containing"276"
tobramycin,"gentamicin"and"combinations"of"both"antibiotics"with"the"different"277"
preparations" of" lactoferrin" were" all" prepared" locally." Antibiotic" discs" were"278"
applied"to"the"agar"following"inoculation"with"E*coli"and"plates"were"incubated"279"
for"24"hours"at"37°C.""Zones"of"inhibition"were"measured"after"this"incubation"280"
period" and" used" to" construct" a" calibration" curve" for" antibiotic" effects." A"281"
calibration" plot" of" the" diameter" of" the" zone" of" inhibition" against" log"282"
concentration" (for" antibiotic" discs" containing" 1" –" 10,000" µg)" was" used" to"283"
determine" the" concentration" of" the" antibiotic" in" the" combination" discs" that"284"
passed" through" the" biofilms." The" diameter" of" the" zones" of" inhibition" in" the"285"
controls" (no" biofilm)" were" taken" to" signify" 100%" penetration" and" used" to"286"
determine" the" percent" penetration" of" the" antibiotics" through" the" biofilms."All"287"
experiments"were"performed" in" triplicates"and"a" two`tailed,"paired" t`test"was"288"
used" for" statistical" analysis." In" order" to" avoid" false" negative" results" arising"289"
from" side" diffusion" from" the" antibiotic" disc" around" the" biofilm," rather" than"290"
through"the"biofilm,"only"biofilms"<13"mm"in"diameter"were"used"in"this"assay.""291"
"292"
2.8"Confocal"imaging"of"non`viable"bacteria"in"biofilms.""293"
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"294"
Reusable" silicone" incubation" chambers" (Flexwell™," Grace" Bio`Labs)" were"295"
used"to"create"8"chambers"on"glass"coverslips"into"which"P.*aeruginosa"was"296"
seeded"and"incubated"for"72"hours"in"order"to"produce"biofilms.""A"1ml"aliquot"297"
of" the" cell" suspension" (~" 107" cfu/ml)"was"added" into" each"of" the" chambers"298"
and"incubated"at"37°C,"with"CAA"medium"refreshed"every"16"hours."Following"299"
72" hours" growth" of" the" biofilms" on" the" coverslip," the" CAA" medium" was"300"
removed" and" wells" were" carefully" washed" twice" with" phosphate`buffered"301"
saline"(PBS)"to"remove"planktonic"bacteria."Biofilms"were"treated"for"24"hours"302"
at" 37°C" with" 200" µl" of" 1 g/ml" tobramycin," ApoLf" or" Tobi+ApoLf." Positive"303"
controls" (viable" bacteria)" contained" 200" µL" of" CAA" media" without" any"304"
antibiotic,"whilst"the"negative"control"(dead"bacteria)"was"treated"with"200"µL"305"
of" isopropanol." The" biofilms" were" washed" with" PBS" and" stained" with"306"
LIVE/DEAD!"BacLight™" bacterial" viability" kit" (Invitrogen," Life" Technologies,"307"
Ltd,"Paisley,"UK)"using"a"mixture"of"3"μl"of"SYTO!"9"with"3"μl"of"propidium"308"
iodide"per"ml"of"saline,"as"per"the"manufacturer’s"instructions.""309"
Visualisation" of" antibiotic/combination" treated" and" untreated" biofilms" was"310"
carried" out" using" a" Leica" tandem" confocal" scanner" SP5" confocal" laser"311"
scanning" microscope" (CLSM]" Leica" Microsystems," Milton" Keynes," UK)."312"
Images" were" obtained" using" 20x" HC" PL" APO"with" 20x/0.70" CS" lens." " For"313"
detection"of"SYTO!"9"(green"channel),"the"488"nm"line"of"the"argon"laser"with"314"
a" detection" bandwidth" of" 495" –" 515" nm" was" employed." For" detection" of"315"
propidium" iodide" (red" channel)," the" 561" nm" HeNe" laser" was" used" with" a"316"
detection"bandwidth"of"615"–"600"nm.""Image"analysis"was"carried"out"using"317"
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Leica"LAS"AF"2.2.1"software."318"
"319"
2.9"Statistical"analysis."320"
"321"
All"experiments"were"performed" in" independent" triplicate"analysis"of"multiple"322"
repeats."Two`tailed,"unpaired"t`tests"or"two`way"Anova"with"Tukey’s"post"hoc"323"
were"used" for" statistical" analysis."Statistical" analyses"were"performed"using"324"
GraphPad"Prism"5.325"
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3." RESULTS"326"
"327"
The" effect" of" spray" drying" on" the" antimicrobial" activity" of" Lf" and"ApoLf"was"328"
evaluated" for" planktonic" P.* aeruginosa* PAO1" over" a" 60`minute" incubation"329"
period"(Fig."2).""Lf"produced"over"2"log"reductions"in"bacterial"number"after"60"330"
minutes,"whereas"SD" Lf"was" slightly" less" effective" (<2" log" reductions" in" 60"331"
minutes)." The" kinetics" of" the" action" of" Lf" and" SDLf" were" very" similar," with"332"
most"activity"apparent" in" the" first"10"minutes"of" incubation."ApoLf"was"more"333"
effective" than" Lf" `" 60" minutes" incubation" with" ApoLf" reduced" bacterial"334"
numbers"by"over"5"log10"cfu/ml.""Although"spray"drying"reduced"the"activity"of"335"
ApoLf," this"was"still"greater" than"Lf"`" indicating"that"ApoLf,"even"when"spray"336"
dried,"is"the"more"active"antimicrobial"form"of"the"protein."""337"
"338"
Aminoglycosides"were"spray"dried"with" the"antimicrobial"proteins"and" tested"339"
for"their"ability"to"kill"planktonic"organisms.""The"data"in"Fig."4A"indicated"that"340"
spray"dried"tobramycin"at"2µg/ml"produced"a"2"log"reduction"in"cfu/ml"over"60"341"
minutes," but" that" this" activity"was" significantly" (p<0.05)" increased"when" the"342"
antibiotic"was"co`spray"dried"with"either"Lf"or"ApoLf.""The"combination"of"TOBI"343"
with"ApoLf"was"the"most"effective"and"resulted"in"over"5"log"reductions"in"cfu"344"
over"duration"of" the"assay." "The"combination"of"Genta"with"Lf"or"ApoLf"was"345"
also"more"effective"in"terms"of"planktonic"bacterial"killing"in"comparison"to"the"346"
mono`treatment"with" the"aminoglycoside"alone" (Fig."4B)." "Here," spray"dried"347"
Genta" was" shown" to" be" effective" and" reduce" the" cfu" by" 2" logs" over" 60"348"
minutes,"but"when"Gm"was"co`spray"dried"with"Lf,"this"killing"was"enhanced"to"349"
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almost" 4" log" reductions" and" again," ApoLf" with" Gm"was"most" effective" and"350"
resulted"in"100%"bacterial"eradication"within"40"minutes."351"
"352"
The" particle" size" distribution" (PSD)" and" aerodynamic" performance" of" the"353"
spray"dried"and"co`spray"dried"formulations"is"shown"in"Table"1A"and"B."The"354"
d50"of"the"spray"dried"and"co`spray"dried"particles"was"between"1.5"–"1.9"µm"355"
with"90%"of"particles"below"5µm."356"
"357"
Following"aerosolisation"of"the"different"spray"dried"formulations,"the"%EF"of"358"
ranged"between"88"–"97%."Whilst"%EF"is"a"measure"of"how"well"the"powder"359"
is" removed" from" the"device," the"FPFRD" is" the"measure"of" the"aerosolisation"360"
efficiency."The"%FPF"of"the"spray"dried"Lf"and"ApoLf"was"lower"than"that"of"361"
Tobi"and"Genta."The"co`spray"dried"formulation"also"had"high"%EF"(range:"91"362"
–" 94%" for" both" agents)" and" the"%FPF" ranged" from" 35" –" 42%" for" both" the"363"
antibiotic" and" protein" fraction" of" the" co`spray" dried" particles."Moreover," the"364"
%FPF"of" each" agent"was" very" similar" suggesting" that"were" likely" to" be" co`365"
delivered."""366"
"367"
The"effects"of"the"spray"dried"antibiotics"and"combinations"were"examined"for"368"
their" effects" on" biofilms" of" PAO1" using" the" crystal" violet" assay." " Figure" 5A"369"
shows" that" SD" TOBI" reduced" the" biofilm" intensity" in" the" first" 24" hours" to"370"
57.4±0.1"%" control." However," co`spray" drying" TOBI"with" either" Lf" or" ApoLf"371"
significantly" (P<0.01)" enhanced" this" reduction" to" 24.8±0.8" or" 22.9±0.8" %"372"
control,"respectively.""A"similar"pattern"of"biofilm"inhibition"was"observed"after"373"
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24`hour"treatment"with"SD"Genta,"which"suggested"that"biofilm"intensity"was"374"
reduced" to" 56.9±7.8%." Co`spray" drying" Genta" with" Lf" or" ApoLf" showed"375"
significant" (P<0.01)" reduction" in" biofilm" intensity" to" 30.5±1.5" or" 23±0.6" %"376"
control" following" co`spray" drying" Genta" with" Lf" or" ApoLf," respectively.""377"
Interestingly," the" combination" treatments" appeared" more" effective" on" pre`378"
formed"biofilms" (Fig."5B)." "Here,"biofilms"were"allowed" to" form" for"24"hours"379"
prior"to"the"addition"of"SD"aminoglycosides"or"co`spray`dried"protein`antibiotic"380"
formulations." Under" these" conditions," the" effects" of" Lf`aminoglycoside"381"
combinations" were" less" impressive," with" SD" TOBI+Lf" reducing" the" biofilm"382"
intensity"to"63.7±11.6%"whilst"co`spray"dried"Genta+Lf"only"reduced"intensity"383"
to"86.7±10.3"%." "However,"spray`dried"combinations"of" the"aminoglycosides"384"
with" ApoLf" were" still" effective" at" significantly" (P<0.01)" reducing" biofilm"385"
intensity" to" 27.4±7" or" 31.5±7.8%" for" co`spray" dried" TOBI+ApoLF" or"386"
Genta+ApoLf"respectively."387"
"388"
Since" the" SD" combinations" were" effective" at" reducing" biofilm" intensity," the"389"
mechanism"of"action"of" this"effect"was" investigated"by"examining"the"effects"390"
of" the" antimicrobial" proteins" on" penetration" of" the" SD" antibiotics" through"391"
PAO1"biofilms."The"zones"of"growth"inhibition"of"the"indicator"organism"in"the"392"
absence"of"a"biofilm"were" taken" to" represent"100%"penetration"and"used" to"393"
determine" the" percentage" retardation" of" the" penetration" of" antibiotics" and"394"
combinations" through"PAO1"biofilms."The" limit"of"detection"was" taken" to"be"395"
13mm,"since"this"was"size"of"the"polycarbonate"membrane"filter"on"which"the"396"
biofilms"were"grown."""397"
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"""398"
Figure"6"indicated"that"PAO1"biofilms"reduced"the"penetration"of"SD"TOBI"to"399"
15.3±6.3%"and"spray"dried"combinations"of"Lf"with"TOBI"did"not"significantly"400"
alter" this" (drug" penetration" 23±4%" control)." In" contrast," the" spray`dried"401"
combination"of"ApoLf"with"TOBI" significantly" (P<0.05)" increased"penetration"402"
of"the"antibiotic"through"PAO1"biofilms"to"42.4±11.7"%."Visualisation"of"viable"403"
bacteria" within" the" biofilm" (Fig." 7)" indicated" that" SD" combinations" of" ApoLf"404"
with" TOBI" are" more" effective" at" reducing" bacterial" viability" than" SD" TOBI"405"
alone." " Biofilms" were" grown" on" glass" slides" for" 72" hours" in" order" to" allow"406"
confocal"fluorescence"microscopy"using"the"nucleic"acid"stains,"SYTO"9"and"407"
propidium" iodide." "While"SYTO"9" stains" all" nuclei" acid" in" a" population" (and"408"
therefore" bacteria" with" intact" and" damaged" membranes" appear" green),"409"
propidium" iodide" stains" only" bacteria" with" damaged"membranes."When" the"410"
two"dyes"are"used"together,"propidium"iodide"staining"of"damage"bacteria"will"411"
cause" a" reduction" in" their" green" fluorescence," visible" as" an" increase" in" the"412"
yellow"intensity"seen"on"overlay"of"the"green"and"red"channel"images.""These"413"
experiments" evaluated" the" effects" of" co`spray" dried" TOBI+ApoLf," since" this"414"
combination"consistently"performed"most"effectively." "Fig."7B"shows"that"SD"415"
ApoLf"reduces"bacterial"viability"(apparent"from"the"yellow"staining"in"the"right"416"
panel),"whereas"SD"TOBI"is"not"altering"bacterial"viability"and"the"staining"is"417"
predominantly" in" the" green" channel" (Fig." 7C)." " The" images" in" Fig." 7D"418"
indicated" that" co`spray" dried" TOBI+ApoLf" was" most" effective" in" terms" of"419"
reducing" bacterial" viability" in" the" biofilm`" thus" red" fluorescence"was" greater"420"
here" than" with" the" other" compounds" tested" and" the" intensity" of" the" yellow"421"
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overlay" indicating" dead" bacteria" is" greatest" after" incubation" with" co`spray"422"
dried"TOBI+ApoLf."423"
""424"
4."DISCUSSION"425"
"426"
The" idea"of"combining"various"antibiotics" to" increase"their"efficacy"has"been"427"
around" for" decades." In" the" present" study," we" investigated" the" in" vitro"428"
antibacterial"activities"of"a"novel"inhaled"antibiotic"combination"consisting"of"a"429"
1:1"spray"dried"combination"of"aminoglycosides"and"an"antimicrobial"peptide"430"
(Lactoferrin)." Upon" spray" drying" our" various" preparations," we" obtained" an"431"
average"residual"moisture"content"of"between"3.2"–"5.9"%"indicating"that"the"432"
drying"process"was"efficient"in"evaporating"most"of"the"moisture.""433"
"434"
To" better" understand" the" activities" of" our" paired" agents" against" both"435"
planktonic" and" biofilms" of" P.aeruginosa," we" carried" out" various" time`kill"436"
experiments" to" ascertain" the" rate" and" degree" of" bacterial" killing" by" the"437"
individual"agents"as"well"as"in"combination"(Fig."2"and"4)."Our"results,"indicate"438"
that" following"spray"drying"all" the"antibiotics"were"able" to" reduce" the"colony"439"
forming" unit" per" mililitre" (cfu/ml)" by" 3" Log" units" within" 60" mins" when"440"
administered" at" high" concentrations," but" on" combining" both" agents," we"441"
discovered" that" there" was" a" much" rapid" bactericidal" effect" at" very" low"442"
concentrations"compared"to"the"individual"administrations.""443"
"444"
Similarly," in" other" to" ascertain" the" effectiveness" of" our" spray" dried"445"
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combinations" either" in" preventing" biofilm" formation" or" in" depleting" already"446"
formed"biofilms."We"employed"a"method"which"effectively"measured"biofilm"447"
mass"by"quantifying"the"amount"of"crystal"violet"retained"by"a"microtitre"plate"448"
in" which" biofilms" had" been" previously" grown," washed" and" stained." Our"449"
findings" from" these" experiments," showed" that" there" was" a" significant"450"
decrease"in"both"the"initiation"and"persistence"of"biofilms"when"incubated"with"451"
the" various" lactoferrin" preparations." Interestingly," this" observed" decrease" in"452"
both" initiation"and"persistence"were"both"absent"on"exposing" the"biofilms" to"453"
the" aminoglycoside" alone" but" reappears" on" combining" the" aminoglycosides"454"
with"lactoferrin.""455"
"456"
Furthermore," to"better"understand"how"our"paired"agents"are"able" to"disrupt"457"
the" biofilms" matrix," we" employed" the" method" whose" schematic" is" briefly"458"
described" in" figure" 1." Results" obtained" from" our" penetration" experiments"459"
indicated"that"our" tobramycin:lactoferrin"combination"permitted"a"significantly"460"
higher"amount"of"solute"through"the"model"biofilms."However,"it"is"understood"461"
that" in" vitro" antibiotic" activity"may" not" always" correlate" with" in" vivo" activity,"462"
particularly"in"CF"because"CF"sputum"has"been"shown"to"inhibit"the"activity"of"463"
aminoglycosides"(Mendelman"et"al.,"1985]"Hunt"et"al.,"1995)."464"
"465"
Previous" studies" have" demonstrated" that" lactoferrin," tobramycin" and"466"
gentamicin" are" able" to" impart" negatively" on" the" viability" of" P.* aeruginosa"467"
biofilms"(P."K."Singh"et"al.,"2002]"Tré`Hardy"et"al.,"2008]"Khan"et"al.,"2011)."468"
However," the" effect" of" micron" sized" combinations" of" lactoferrin`tobramycin"469"
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and" lactoferrin`gentamicin" has" not" been" investigated." Thus," these" studies"470"
show"the"potential"benefit"such"a"formulation"would"have.""471"
"472"
Images" obtained" by" confocal" laser" scanning" microscopy" CLSM" show" that"473"
both"apo" lactoferrin"and" tobramycin"caused"minimal"cell"membrane"damage"474"
to"majority" of" the" biofilm" cells." However," treatment" of" the" biofilms" with" a" 1"475"
mg/ml" spray" dried" combination" of" lactoferrin" and" tobramycin" caused"476"
significant" membrane" damage" to" all" cells" indicating" cell" lysis" in" the" P.*477"
aeruginosa"PAO1"biofilm."These"observations"were"consistent"with"our"biofilm"478"
and" penetration" assays." Taken" together," our" confocal" microscopy" results"479"
indicate"that"on"treating"the"biofilms"with"a"spray"dried"combination"therapy"of"480"
lactoferrin" and" tobramycin" there" is" a" complete" suppression" of" metabolic"481"
activity" of" biofilms" due" to" the" enhanced" antibiotic" penetration" through"482"
disrupted"cell"membranes."483"
"484"
Overall," results" from" our" study" show" that" the" spray" dried" combinations" of"485"
aminoglycosides" and" lactoferrin" appear" to" have" a" superior" antimicrobial"486"
activity" in" P.* aeruginosa" PAO1" biofilms" compared" to" monotherapy."487"
Tobramycin:lactoferrin" combination" could" be" a" potentially" new" therapeutic"488"
agent" for" biofilm" associated" infections." Also" the" fact" that" as" a" combination"489"
they"can"be"homogeneously"micronized"means"that"they"could"potentially"be"490"
employed" in" the"management"of" chronic"airway" infections"as"seen"amongst"491"
people"with"cystic"fibrosis."The"clinical"applicability"of"a"tobramycin:lactoferrin"492"
combination"warrants"future"in"vivo"studies"493"
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Drug" resistant" bacterial" infections" are" becoming"more"widespread"with" new"494"
drug"approvals" for" inhaled"antibiotics"constantly"declining"year"on"year."The"495"
rise" in" drug" resistance" especially" due" to" the" ability" of" bacteria" to" exist" in"496"
biofilms"has"limited"the"repertoire"of"effective"antimicrobials"with"considerable"497"
potency" against" infections" as" commonly" seen" amongst" people" with" cystic"498"
fibrosis."The"potential" for"employing"a"combination"therapy"of" lactoferrin"and"499"
aminoglycoside"as"described"here"provides"a"new"and"large"playing"field"for"500"
proper"utilisation"of"our"currently"available"antibiotic"resources"in"the"provision"501"
of" therapeutic" solutions" to" some" of" the" current" bacterial" menace." It" will" be"502"
interesting"to"translate"most"of"our"understanding"into"clinical"treatment"so"as"503"
to"effectively"fight"resistant"P.*aeruginosa"infections."504"
"505"
5."CONCLUSIONS"506"
In" conclusion," we" have" developed" combination" therapies" comprising" an"507"
antimicrobial"protein"(lactoferrin)"and"an"aminoglycoside"antibiotic"(tobramycin"508"
or" gentamicin)," which" are" more" effective" than" monotherapy" at" reducing"509"
planktonic"cell"viability"and"preventing"biofilm"formation."We"have"shown"that"510"
these"combinations"have"parameters"compatible"with"delivery" to" the"airways"511"
and" sug`" gest," therefore," that" they" represent" an" important" and"exciting"new"512"
therapeutic" strategy" for" treating" biofilm`forming" infections" such" as" those"513"
typical"of"the"CF"lungs."514"
"515"
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TABLES"615"
"616"
Table" 1A." Particle" size" distribution" of" the" spray`dried" particles" and" their"617"
aerodynamic"performance"as"determined"by" the"percentage"emitted" fraction"618"
(%EF)"and"percentage"fine"particle"fraction"of"recovered"dose"(%FPFRD)."619"
"620"
Formulation" d[v,10]"(µm)" d[v,50]"(µm)" d[v,90]"(µm), %EF" %FPFRD"
SD"Lf" 0.8"±"0.2" 1.9"±"0.3" 4.08"±"0.4" 96.2"±"0.4" 28.6"±"0.3"
SD"ApoLf" 0.7"±"0.3" 1.7"±"0.2" 4.01"±"0.5" 93.9"±"0.5" 31.9"±"0.6"
SD"Tobi" 0.8"±"0.6" 1.7"±"0.6" 4.78"±"0.8" 88.9"±"3.2" 38.7"±"1.4"
SD"Genta" 0.8"±"0.1" 1.8"±"0.2" 4.38"±"0.2" 90.5"±"0.1" 40.7"±"1.7"
"621"
"622"
Table" 1B." Particle" size" distribution" of" the" co`spray" dried" particles" and" their"623"
aerodynamic"performance"as"determined"by" the"percentage"emitted" fraction"624"
(%EF)"and"percentage"fine"particle"fraction"of"recovered"dose"(%FPFRD)."625"
"626"
Formula
tion"
d[v,10]"
(µm)"
d[v,50]"
(µm)"
d[v,90]"
(µm),
%EF"
(Aminog
lycoside
)"
%EF"
(Protein)"
%FPFRD"
(Aminog
lycoside
)"
%FPFRD"
(Protein)"
SDLf" +"
Tobi"
0.9" ±"
0.4"
1.8" ±"
0.6"
4.56" ±"
0.8"
92.6" ±"
0.3"
91.9" ±"
0.4"
35.3" ±"
2.2"
36.8" ±"
1.8"
SD" 0.9" ±" 1.8" ±" 4.01" ±" 91.7" ±" 90.9" ±" 38.9" ±" 37.2" ±"
29"
 
"
ApoLf" +"
Tobi"
0.3" 0.3" 0.3" 0.8" 0.9" 3.9" 1.5"
SD" Lf" +"
Genta"
0.7" ±"
0.4"
1.6" ±"
0.5"
4.05" ±"
0.1"
91.6" ±"
0.5"
92.3" ±"
0.7"
42.3" ±"
2.3"
40.9" ±"
1.9"
SD"
ApoLf" +"
Genta"
0.7" ±"
0.4"
1.5" ±"
0.2"
4.28" ±"
0.3"
93.5" ±"
0.8"
94.2" ±"
0.6"
35.1" ±"
2.8"
36.8" ±"
1.2"
"627"
"628"
FIGURES"629"
"630"
Figure"1."Schematic"depiction"of"the"experimental"setup"used"to"analyse"the"631"
penetration"of"antibiotics"and"combinations"of"antibiotics"with" lactoferrin/apo`632"
lactoferrin,"through"P.*aeruginosa"biofilms.""Biofilms"were"grown"for"48"hours"633"
before"use"in"this"penetration"assay."""634"
"635"
Figure" 2." Spray" drying" antimicrobial" proteins" antimicrobial" activity."636"
Apolactoferrin"and"SD"apolactoferrin"were"significantly"more"effective"than"the"637"
iron`rich"form"(P<0.05)"and"resulted"in"4`5"log"reductions"in"bacterial"numbers"638"
over" 60" minutes." Control" (no" antimicrobial" protein)," !]" Lactoferrin," "]" SD"639"
lactoferrin,"#]"Apolactoferrin,"!]"SD"apolactoferrin," ."Data"are"presented"as"640"
mean±SD,"n=3"independent"experiments.""641"
"642"
Figure" 3." Effects" of" the" compounds" on" initiation" of" the" biofilm," where"643"
compounds"were"present"throughout"24"hours"of"culture"(A)"and"the"effects"of"644"
30"
 
"
the" compounds" on" an" established" biofilm," here" compounds"were" added" 24"645"
hours"after"biofilm"formation"and"incubated"for"a"further"24"hours"(B)."Data"are"646"
presented"as"a"percentage"of"control`"where"the"intensity"of"the"biofilm"in"the"647"
absence"of"any"agents"(control)"was"given"the"value"100"%"and"all"other"data"648"
are"expressed"relative"to"this."Data"are"shown"as"mean"±"standard"deviation"649"
of"8"repeats"from"triplicate"analysis."650"
"651"
Figure" 4." Effect" of" spray" dried" combinations" of" aminoglycosides" with"652"
antimicrobial" proteins" on" planktonic" bacterial" killing." A:" Combinations" of"653"
tobramycin"with"Lf" or"ApoLf"and"B:"Combinations"of" gentamicin"with"Lf" and"654"
ApoLf."655"
"656"
Figure" 5." Effects" of" the" combinations" of" tobramycin" and" on" initiation" of" the"657"
biofilm,"where"the"antibiotic"or"combination"was"present"throughout"24"hours"658"
of"culture"(A)"and"effects"of"the"combinations"on"an"established"biofilm"(B)."659"
"660"
Figure"6."Investigation"of"the"penetration"of"combination"therapies"of"antibiotic"661"
with"lactoferrin"or"apolactoferrin"PAO1"biofilms."662"
"663"
Figure" 7." Confocal" imaging" of" bioflms" following" exposure" to" spray`dried"664"
combinations"of"Tobi"and"ApoLf.""665"
"666"
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